AKT2 and hematopoietic and lymphoid system neoplasm: With an ideal sensitivity and specificity of 100% and 99%, respectively, the combination of the AKT2 gene and miRNA-4716–3p demonstrated exceptional discriminatory ability in differentiating blood cancer from healthy individuals, with an AUC of 0.893 (p < 0.0001).